Alps Advisors Inc Amgen Inc Transaction History

Alps Advisors Inc

  • $14.8 Billion
  • Q3 2024

A detailed history of Alps Advisors Inc transactions in Amgen Inc stock. As of the latest transaction made, Alps Advisors Inc holds 11,911 shares of AMGN stock, worth $3.17 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,911
Previous 25,000 52.36%
Holding current value
$3.17 Million
Previous $7.81 Million 50.88%
% of portfolio
0.03%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$309.38 - $337.38 $4.05 Million - $4.42 Million
-13,089 Reduced 52.36%
11,911 $3.84 Million
Q2 2024

Aug 13, 2024
BUY
$262.75 - $319.31 $450,090 - $546,978
1,713 Added 7.36%
25,000 $7.81 Million
Q1 2024

May 14, 2024
SELL
$268.87 - $324.56 $271,558 - $327,805
-1,010 Reduced 4.16%
23,287 $6.62 Million
Q4 2023

Feb 14, 2024
SELL
$255.7 - $288.46 $14,063 - $15,865
-55 Reduced 0.23%
24,297 $7 Million
Q3 2023

Nov 14, 2023
SELL
$218.65 - $271.46 $1.54 Million - $1.92 Million
-7,066 Reduced 22.49%
24,352 $6.54 Million
Q2 2023

Aug 14, 2023
SELL
$214.27 - $253.37 $178,486 - $211,057
-833 Reduced 2.58%
31,418 $6.98 Million
Q1 2023

May 10, 2023
SELL
$225.79 - $275.2 $697,691 - $850,368
-3,090 Reduced 8.74%
32,251 $7.8 Million
Q4 2022

Feb 14, 2023
SELL
$229.03 - $291.01 $23.2 Million - $29.5 Million
-101,301 Reduced 74.14%
35,341 $9.28 Million
Q3 2022

Nov 14, 2022
SELL
$224.46 - $253.15 $6.96 Million - $7.85 Million
-31,007 Reduced 18.5%
136,642 $30.8 Million
Q2 2022

Aug 11, 2022
BUY
$230.71 - $256.74 $13.9 Million - $15.5 Million
60,453 Added 56.39%
167,649 $40.8 Million
Q1 2022

May 16, 2022
SELL
$219.27 - $242.57 $661,976 - $732,318
-3,019 Reduced 2.74%
107,196 $25.9 Million
Q4 2021

Feb 09, 2022
BUY
$198.88 - $227.6 $21.9 Million - $25.1 Million
110,215 New
110,215 $24.8 Million
Q1 2021

May 07, 2021
SELL
$221.91 - $258.6 $236,556 - $275,667
-1,066 Closed
0 $0
Q4 2020

Feb 03, 2021
SELL
$216.38 - $257.67 $4,543 - $5,411
-21 Reduced 1.93%
1,066 $245,000
Q3 2020

Nov 04, 2020
BUY
$234.65 - $260.95 $26,750 - $29,748
114 Added 11.72%
1,087 $276,000
Q2 2020

Aug 05, 2020
SELL
$197.81 - $242.74 $21,363 - $26,215
-108 Reduced 9.99%
973 $229,000
Q1 2020

May 06, 2020
SELL
$182.24 - $241.7 $1.48 Million - $1.96 Million
-8,100 Reduced 88.23%
1,081 $219,000
Q4 2019

Feb 07, 2020
SELL
$189.21 - $243.2 $70,386 - $90,470
-372 Reduced 3.89%
9,181 $2.21 Million
Q3 2019

Nov 04, 2019
SELL
$174.11 - $208.62 $690,172 - $826,969
-3,964 Reduced 29.33%
9,553 $1.85 Million
Q2 2019

Aug 07, 2019
SELL
$166.7 - $195.41 $34,340 - $40,254
-206 Reduced 1.5%
13,517 $2.49 Million
Q1 2019

May 01, 2019
SELL
$180.87 - $203.88 $1.3 Million - $1.47 Million
-7,192 Reduced 34.39%
13,723 $2.61 Million
Q4 2018

Feb 04, 2019
BUY
$178.4 - $208.25 $22,656 - $26,447
127 Added 0.61%
20,915 $4.07 Million
Q3 2018

Oct 25, 2018
BUY
$185.29 - $208.89 $2.27 Million - $2.55 Million
12,226 Added 142.79%
20,788 $4.31 Million
Q2 2018

Aug 02, 2018
BUY
$166.05 - $186.51 $504,293 - $566,430
3,037 Added 54.97%
8,562 $1.58 Million
Q2 2018

Jul 25, 2018
BUY
$166.05 - $186.51 $86,179 - $96,798
519 Added 10.37%
5,525 $961,000
Q1 2018

May 01, 2018
SELL
$169.43 - $198.0 $87,934 - $102,762
-519 Reduced 9.39%
5,006 $853,000
Q4 2017

Feb 05, 2018
BUY
$168.79 - $188.59 $46,586 - $52,050
276 Added 5.26%
5,525 $961,000
Q3 2017

Nov 03, 2017
BUY
$167.29 - $191.0 $878,105 - $1 Million
5,249
5,249 $979,000

Others Institutions Holding AMGN

# of Institutions
3,126
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $142B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email